Combination of the MEK inhibitor, pimasertib (MSC1936369B), and the PI3K/mTOR inhibitor, SAR245409, in patients with advanced solid tumors: Results of a phase Ib dose-escalation trial Meeting Abstract
| Authors: | Infante, J. R.; Gandi, L.; Shapiro, G.; Rizvi, N.; Burris, H. A.; Bendell, J. C.; Baselga, J.; Hsu, K.; von Richter, O.; Locatelli, G.; Asatiani, E.; Heist, R. S. |
| Abstract Title: | Combination of the MEK inhibitor, pimasertib (MSC1936369B), and the PI3K/mTOR inhibitor, SAR245409, in patients with advanced solid tumors: Results of a phase Ib dose-escalation trial |
| Meeting Title: | 104th Annual Meeting of the American Association for Cancer Research (AACR) |
| Journal Title: | Cancer Research |
| Volume: | 73 |
| Issue: | 8 Suppl. |
| Meeting Dates: | 2013 Apr 6-10 |
| Meeting Location: | Washington, DC |
| ISSN: | 0008-5472 |
| Publisher: | American Association for Cancer Research |
| Date Published: | 2013-04-15 |
| Language: | English |
| ACCESSION: | WOS:000331220601086 |
| DOI: | 10.1158/1538-7445.am2013-lb-147 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: LB-147 -- 104th Annual Meeting of the American-Association-for-Cancer-Research (AACR) -- APR 06-10, 2013 -- Washington, DC -- 1 -- Source: Wos |
